Cemiplimab (Libtayo) for Cutaneous Squamous Cell Carcinoma — Details (Libtayo) (Last Updated: Feb 6, 2020)
Treatment of adult patients with
cardiomyopathy due to transthyretin-mediated amyloidosis, wild-type or
hereditary, to reduce cardiovascular
mortality and cardiovascular-related hospitalization.
iron deficiency anemia
Indicated in combination with a SSRI or SNRI, for the treatment of major depressive disorder in adults who have not responded adequately to at least two separate courses of treatment with different antidepressants, each of adequate dose and duration, in the current moderate to severe depressive episode.